Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

By afschroeder • October 10, 2025

Shin AS, Xing Y, Waseem MR, Siwiec R, James-Stevenson T, Rogers N, Bohm M, Wo J, Lockett C, Gupta A, Kadariya J, Toh E, Anderson R, Dong A, Xu H, Gao X. Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS). Sci Rep. 2025 Oct 9;15(1):35375. doi: 10.1038/s41598-025-19363-2. PMID: 41068306; PMCID: PMC12511408.

Tags: Bile acid metabolism, Colonic microflora, Digestive Diseases, Functional gastrointestinal disorder, Gut-brain interaction, microbiome, Publications

Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy

Shaikh A, Lee TH, Lymberopoulos P, Benhammou JN, Rich N, Agopian VG, Hernaez R, Goss J, Singal AG, El-Serag HB, Rana A, Kanwal F, Berg[...]

JPEN Journal Club 97. Splitting studies

Koretz RL. JPEN Journal Club 97. Splitting studies. JPEN J Parenter Enteral Nutr. 2025 Nov 16. doi: 10.1002/jpen.70035. Epub ahead of print. PMID: 41241824.

Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis

Young AC, Andréasson K, Labus J, Matulionis N, Jacobs JP, Christofk H, Volkmann ER. Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis.[...]